Structures by: Tenorio J. C.
Total: 34
(+-)-3-<i>tert</i>-Butyl-4-(4-chlorophenyl)-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>e</i>][1,4]thiazepin-7(4<i>H</i>,6<i>H</i>,8<i>H</i>)-one
C22H22ClN3OS
IUCrData (2016) 1, 4 x160608
a=9.7478(3)Å b=25.2229(8)Å c=8.6354(2)Å
α=90° β=101.733(2)° γ=90°
PRX-FUM
C19H21FNO3,C4H3O4
CrystEngComm (2019) 21, 24 3668
a=7.2223(3)Å b=7.9950(10)Å c=18.538(2)Å
α=78.672(10)° β=82.396(5)° γ=85.860(7)°
PRX-OXA
C2O4,2(C19H21FNO3),0.5(O2H4)
CrystEngComm (2019) 21, 24 3668
a=18.960(3)Å b=6.7993(11)Å c=29.935(5)Å
α=90° β=91.638(14)° γ=90°
PRX-TART
0.5(C4H4O6),0.5(C4H6O6),C19H21FNO3,0.5(H2O)
CrystEngComm (2019) 21, 24 3668
a=14.3395(17)Å b=7.9557(9)Å c=19.608(2)Å
α=90° β=97.036(2)° γ=90°
PRX-MAL
C19H21FNO3,C4H3O4
CrystEngComm (2019) 21, 24 3668
a=11.629(2)Å b=11.649(2)Å c=17.584(5)Å
α=77.740(4)° β=77.333(4)° γ=71.079(3)°
4-(Pyridin-2-yl)pyrimidin-2-amine
C9H8N4
Acta Crystallographica Section C (2019) 75, 12
a=11.4608(15)Å b=5.3791(9)Å c=26.740(4)Å
α=90° β=91.457(12)° γ=90°
4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
C14H7ClN2O7
Acta Crystallographica Section E (2015) 71, 12 o940
a=7.7366(2)Å b=7.9480(2)Å c=12.6539(5)Å
α=90.0655(11)° β=100.3204(11)° γ=104.0633(12)°
4-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)benzoic acid
C11H7NO4
Acta Crystallographica Section C (2011) 67, 2 o67-o70
a=7.3326(5)Å b=9.8832(5)Å c=13.3922(11)Å
α=90.00° β=90.00° γ=90.00°
2,4,6-Trinitrophenyl 3-bromobenzoate
C13H6BrN3O8
Acta Crystallographica Section E (2014) 70, 6 o689
a=11.2925(4)Å b=9.5672(3)Å c=14.0560(6)Å
α=90.00° β=94.625(2)° γ=90.00°
9-(4-bromobutyl)-9<i>H</i>-carbazole
C16H16BrN
Acta Crystallographica Section E (2012) 68, 6 o1853
a=16.0949(4)Å b=7.7012(2)Å c=22.6874(4)Å
α=90.00° β=90.00° γ=90.00°
2,2'-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
C26H26S4
Acta Crystallographica Section E (2014) 70, 2 o117
a=8.6981(6)Å b=11.7074(7)Å c=12.5612(6)Å
α=90.00° β=107.626(4)° γ=90.00°
2,4,6-trinitrophenyl 3-methylbenzoate
C14H9N3O8
Acta Crystallographica Section E (2012) 68, 7 o2187
a=7.49470(10)Å b=8.4366(2)Å c=23.8574(6)Å
α=90.00° β=99.3650(10)° γ=90.00°
3,5-Bis(benzyloxy)benzoic acid
C21H18O4
Acta Crystallographica Section E (2012) 68, 11 o3247-o3248
a=5.2801(2)Å b=11.6830(5)Å c=14.4803(7)Å
α=83.303(2)° β=80.775(2)° γ=79.0310(10)°
2,4,6-Trinitrophenyl 4-methylbenzoate
C14H9N3O8
Acta Crystallographica Section E (2012) 68, 11 o3107
a=7.6126(2)Å b=8.2124(2)Å c=23.9893(7)Å
α=90.00° β=94.4480(10)° γ=90.00°
5-chloroquinolin-8-yl furan-2-carboxylate
C14H8ClNO3
Acta Crystallographica Section E (2013) 69, 4 o501
a=4.07140(10)Å b=23.7463(7)Å c=12.7698(4)Å
α=90.00° β=102.1130(10)° γ=90.00°
2,4,6-trinitrophenyl 4-chlorobenzoate
C13H6ClN3O8
Acta Crystallographica Section E (2013) 69, 4 o570
a=9.3526(3)Å b=11.4793(3)Å c=13.6089(4)Å
α=90.00° β=93.612(2)° γ=90.00°
3-Diphenylaminoisobenzofuran-1(3H)-one
C20H15NO2
Acta Crystallographica Section E (2014) 70, 4 o490
a=19.1440(13)Å b=8.9363(6)Å c=9.1111(3)Å
α=90.00° β=90.00° γ=90.00°
2-[1'-(Benzyloxy)spiro[indane-1,2'-pyrrolidine]-5'-yl]acetonitrile
C21H22N2O
Acta Crystallographica Section E (2013) 69, 8 o1192-o1193
a=9.1688(4)Å b=10.0800(4)Å c=11.4141(6)Å
α=98.826(2)° β=108.777(2)° γ=110.403(4)°
4-Formyl-2-nitrophenyl 4-bromobenzoate
C14H8BrNO5
Acta Crystallographica Section E (2013) 69, 5 o793
a=6.5308(2)Å b=8.2253(2)Å c=25.6860(8)Å
α=90.00° β=103.1910(9)° γ=90.00°
2,4,6-trinitrophenyl 3-chlorobenzoate
C13H6ClN3O8
Acta Crystallographica Section E (2013) 69, 6 o966
a=11.0633(4)Å b=9.6560(4)Å c=14.0251(6)Å
α=90.00° β=94.009(2)° γ=90.00°
2,2'-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
C9H14O4S3
Acta Crystallographica Section E (2013) 69, 5 o774
a=10.4044(2)Å b=10.4947(2)Å c=13.7744(3)Å
α=90.00° β=117.3630(10)° γ=90.00°
(+-)-3-(5-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-2-benzofuran-1(3<i>H</i>)-one
C18H15N3O2
Acta Crystallographica Section E (2013) 69, 7 o1181-o1182
a=10.0451(2)Å b=15.0631(5)Å c=12.2008(4)Å
α=90.00° β=123.257(2)° γ=90.00°
4-Formyl-2-nitrophenyl 2-chlorobenzoate
C14H8ClNO5
Acta Crystallographica Section E (2013) 69, 12 o1806
a=16.2367(7)Å b=7.1047(2)Å c=11.4018(3)Å
α=90° β=90° γ=90°
Cocrystal 5FC succinic acid
C4H4FN3O,0.5(C4H6O4)
Crystal Growth & Design (2014) 14, 9 4383
a=4.9209(3)Å b=8.6115(5)Å c=9.4689(6)Å
α=72.466(3)° β=75.129(3)° γ=89.747(3)°
Cocrystal 5FC adipic acid
C4H4FN3O,0.5(C6H10O4)
Crystal Growth & Design (2014) 14, 9 4383
a=5.2742(5)Å b=6.6650(7)Å c=12.8441(13)Å
α=86.411(6)° β=80.757(6)° γ=71.970(6)°
Cocrystal 5FC tereftalic acid
C4H4FN3O,0.5(C8H6O4)
Crystal Growth & Design (2014) 14, 9 4383
a=3.6265(3)Å b=9.5274(8)Å c=13.7902(12)Å
α=107.812(5)° β=92.036(4)° γ=96.844(4)°
C4H4FN3O,C4H6O5
C4H4FN3O,C4H6O5
Crystal Growth & Design (2014) 14, 9 4383
a=20.8980(4)Å b=14.8590(9)Å c=7.2440(11)Å
α=90° β=107.178(3)° γ=90°
Co-crystal of 5FC with benzoic acid
C11H10FN3O3
Crystal Growth & Design (2014) 14, 9 4383
a=9.0565(2)Å b=5.4318(2)Å c=22.8887(8)Å
α=90° β=92.8700(10)° γ=90°
C4H4FN3O,C4H3FN2O2
C4H4FN3O,C4H3FN2O2
Crystal Growth & Design (2014) 14, 9 4383
a=15.0176(3)Å b=3.56040(10)Å c=27.3113(4)Å
α=90° β=138.2820(10)° γ=90°
Maleate of 5-FC
C8H8FN3O5
Crystal Growth & Design (2013) 13, 10 4315
a=9.3450(5)Å b=11.8620(6)Å c=18.9540(8)Å
α=90° β=113.573(3)° γ=90°
Fumarate monohydrate of 5-FC
C6H8F1N3O4
Crystal Growth & Design (2013) 13, 10 4315
a=3.550(5)Å b=9.093(5)Å c=24.527(5)Å
α=90.000(5)° β=91.737(5)° γ=90.000(5)°
Oxalate of 5-FC
C5H5FN3O3
Crystal Growth & Design (2013) 13, 10 4315
a=5.2610(2)Å b=15.1970(6)Å c=7.8840(3)Å
α=90° β=92.206(3)° γ=90°
C37H35ClNP2Pt,F6P
C37H35ClNP2Pt,F6P
Inorganic chemistry (2015) 54, 24 11709-11720
a=16.7870(2)Å b=13.5500(2)Å c=16.9650(3)Å
α=90° β=111.8020(10)° γ=90°
C37H35ClF6NP3Pt
C37H35ClF6NP3Pt
Inorganic chemistry (2015) 54, 24 11709-11720
a=16.9550(2)Å b=13.7020(2)Å c=16.9720(3)Å
α=90° β=110.8500(10)° γ=90°